Barely Significant
← all excerpts

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).

BMC Urol · 2014 · PMC4167156 · PMID 25062956

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

showed a trendP = 0.01actually significant
It also showed a trend towards improved OS (median not reached, vs. 27.2 months for prednisone alone; HR 0.75; 95% CI, 0.61 to 0.93; P = 0.01).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.